NanoStics
Edmonton, CA · 2 known investors
Nanostics is a precision health company developing non-invasive diagnostic tests and medical devices that use machine learning to detect and assess aggressive cancers such as prostate cancer, aiming to improve diagnosis and healthcare decisions. It serves clinicians and patients in the cancer diagnostics field.
Founders & leadership
Investors · 2
Competitors · 7
by search overlapNanodiagnostics5 shared keywordsNanoDx develops a point-of-care diagnostic system that uses patented nano biosensor technology to detect biomarkers from a small blood sample in minutes. The platform supports multiplexing and adjustable biomarker panels for applications spanning military, urgent care, and sports medicine settings.
Nostics4 shared keywordsNostics develops a portable optical biosensor that measures real-time spectral signals from pathogens in patient samples, using its Spectral Foundation Model to identify infections at the point of care in under 10 minutes. The platform targets healthcare providers seeking rapid, lab-comparable infection diagnostics for decentralized settings and to address antimicrobial resistance.
Nanobiotix4 shared keywordsNanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.
Bioworld3 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
NOWDiagnostics (NOWDx)3 shared keywordsNOWDiagnostics develops rapid, point-of-care and consumer diagnostic tests. The company operates in the medical diagnostics and MedTech industry.
Radionetics3 shared keywordsRadionetics develops small molecule radiopharmaceuticals that target GPCRs, using radioisotope-tethered ligands to image and treat cancerous tumors as part of a theranostics precision medicine approach. The company serves the oncology field with therapeutic and diagnostic radiotherapeutics and is headquartered in San Diego's life sciences community.
Fortis Life Sciences3 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Companies competing with NanoStics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does NanoStics do?
- Nanostics is a precision health company developing non-invasive diagnostic tests and medical devices that use machine learning to detect and assess aggressive cancers such as prostate cancer, aiming to improve diagnosis and healthcare decisions. It serves clinicians and patients in the cancer diagnostics field.
- Who founded NanoStics?
- NanoStics was founded by Dr. John Lewis, John D. Lewis, Robert Paproski.
- Who are NanoStics's investors?
- NanoStics's investors include ScaleGood Fund LP (powered by TELUS), Startup TNT.
- Where is NanoStics headquartered?
- NanoStics is headquartered in Edmonton, CA.